M-063

N/A

Report date: 2024/11/15 14:06:03

Base Information

Drug NameM-063

Drug Alias NameM-063

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionLysosomal alpha-mannosidase stimulantsUDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase stimulants

TargetsLysosomal alpha-mannosidaseUDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase

Therapy Area/Indicationsalpha-Mannosidosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesM6P Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesM6P Therapeutics Ltd

Inactive CompaniesN/A

Active Indicationsalpha-Mannosidosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A